益佰制药 (600594.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(益佰制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 572,646,100.112,820,561,015.002,136,834,252.041,479,701,367.04683,797,926.882,735,262,838.672,099,211,303.231,446,063,415.53687,874,165.98
 营业利润(元) -67,731,162.14137,357,956.51199,307,914.36155,743,625.2354,478,934.30-375,965,200.42250,346,388.94157,764,237.3270,933,548.02
 利润总额(元) -69,765,713.72132,320,704.64194,907,546.17153,642,341.0052,721,310.05-392,066,013.87239,833,220.77150,296,625.3364,363,380.35
 净利润(元) -71,411,782.7891,357,121.13161,499,907.31121,728,393.6141,507,965.53-438,327,454.77194,249,563.62125,785,149.4749,069,972.23
 归属于母公司股东的净利润(元) -68,454,808.45103,399,049.91169,869,961.21127,906,049.2943,999,942.75-426,467,196.36195,999,609.90126,841,647.6050,549,194.35
盈利能力:
 销售毛利率(%) 60.5869.4770.6271.2468.0170.9673.1373.7873.07
 销售净利率(%) -12.473.247.568.236.07-16.039.258.707.13
 净资产收益率(%) -2.253.384.943.781.32----
 总资产报酬率ROA(%) -1.283.073.832.891.05----
 投入资本回报率ROIC(%) -1.722.554.113.061.06-10.054.172.711.13
营运能力:
 存货周转率(次) 0.361.421.010.700.36----
 应收账款周转率(次) 2.3810.829.464.822.38----
 总资产周转率(次) 0.120.580.400.270.13----
偿债能力:
 资产负债率(%) 33.4933.0331.6233.7634.9834.4434.8436.8331.39
 股东权益比率(%) 63.7364.1765.5863.4562.1462.5662.4761.8267.51
 已获利息倍数(倍) -7.659.4818.5860.4962.06-10.7710.7010.9120.69
 流动比率 1.902.232.321.891.771.741.571.521.58
 速动比率 1.161.421.451.221.131.071.061.020.94
发展能力:
 营业收入增长率(%) -16.263.121.792.33-0.59-18.27-19.44-14.29-16.60
 营业利润增长率(%) -224.33136.53-20.39-1.28-23.20-219.20-28.83-22.19-13.58
 税后利润增长率(%) -255.58124.25-13.330.84-12.96-274.94-34.03-25.85-28.79
 净资产增长率(%) -2.900.76-12.30-11.77-13.09-13.103.044.733.44
 总资产增长率(%) -5.32-1.84-16.45-14.04-5.57-3.998.0510.69-1.50

前瞻产业研究院